SCHEDULE 13GAccepted Feb 12, 1:00 PM ET
Aspire Biopharma Holdings, Inc. SCHEDULE 13G
Accepted (ET)
1:00 PM
Feb 12, 2026
Filed
Feb 12, 2026
Documents
3
Size
27.8 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.